Estimates of the Number of Brand-name Drugs Affected by the Medicaid Rebate Cap in 2017.
Where this comes from
- Record sourced from PubMed, PMID 30667469.
- Also identified by DOI 10.1001/jamainternmed.2018.6559 and PMC identifier 6439693.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This analysis of Medicaid reimbursement data examines the financial implications of removing the Medicaid rebate cap.
Medical subject headings
- Drug Costs
- Drug Industry
- Insurance, Pharmaceutical Services
- Medicaid